# US 2016/0355831 A1 · Mortierella alpine uracil auxotroph with ura5 gene knocked out through homologous recombination, and construction method thereof

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0355831 A1
- Document ID: US20160355831A1
- Status: Published application
- Kind: A1
- Application number: 14/910,675
- Filed: 2014-02-21
- Published: 2016-12-08
- Earliest claimed: 2013-08-09
- Assignees: Jiangna University
- Applicants: Jiangna University
- Inventors: Wei Chen; Haiqin CHEN; Yongquan CHEN; Guangfei HAO; Zhennan GU; Jianxin ZHAO; Hao ZHANG; Xiaoyun HUANG; Kai DU; Shanshan ZHAO
- Web page: https://patentgrep.com/patent/US20160355831A1

## CPC

- C12N 15/80: for fungi
- C12N 9/1077: {Pentosyltransferases (2.4.2)}
- C12Y 204/0201: Orotate phosphoribosyltransferase (2.4.2.10)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Y: ENZYMES

## Abstract

It relates to a Mortierella alpine ATCC32222 uracil auxotroph strain and a construction method thereof. In the present invention, Mortierella alpine ATCC32222 is used as a material and undergoes gene knockout through an Agrobacterium tumefaciens mediated genetic manipulation technology, to obtain the Mortierella alpine uracil auxotroph. The method is of great significance for the basic theoretic researches of the oil producing fungus Mortierella alpine ATCC32222 and product development.

## Claims

### Claim 1

A method of constructing a Mortierella alpina ATCC 32222 uracil auxotroph strain, which is generated by inactivating the ura5 encoding orotate phosphoribosyltransferase (OPRTase), deposited at the General Microbiology Culture Collection Center of China Committee for Culture Collection of Microorganisms under accession number CGMCC No.8414.

### Claim 2 (depends on 1)

The method according to claim 1, characterized in that the starting plasmid of Agrobacterium tumefaciens used for gene knockout is pBIG2RHPH2.

### Claim 3 (depends on 2)

The method according to claim 2, characterized in that the inactivation is achieved through the deletion of the 18 bp (from 213 bp to 230 bp) of the 654 bp ura5 genome DNA, characterized in that it inactivates ura5 gene through the deletion of the 18 bp (from 213 bp to 230 bp) of the 654 bp in Mortierella alpina by homologous recombination, in which the homologous DNA sequences are the 1393 bp (from −1180 bp to +212 bp) up-stream and the 1362 bp (from +231 bp to +1592 bp) down-stream of the M. alpina ura5 genome DNA sequence, the steps of the said method are as follows: acquisition of the up- and down-stream sequences of ura5 gene; construction of knockout plasmid pBIG4KOura5; transformation of Agrobacterium tumefaciens C58C1 with plasmid pBIG4KOura5; transformation of M. alpina with the A. tumefaciens C58C1 (harboring pBIG4KOura5) using the Agrobacterium tumefaciens-mediate transformation (ATMT) method, then screening and identifying the uracil auxotroph to obtain the uracil auxotrophic stain of M. alpina.

### Claim 4 (depends on 3)

The method according to claim 3, wherein the uracil auxotrophic stain is Agrobacterium tumefaciens.

### Claim 5 (depends on 4)

The method according to claim 4, wherein the gene knockout plasmid is pBIG2RHPH2.

### Claim 6 (depends on 5)

The method according to claim 5, characterized in that construction of the gene knockout plasmid comprises:
(a) amplifying MCS DNA fragment by PCR using plasmid pBluescript II SK+ as template;
(b) digesting MCS DNA fragment and plasmid pBIG2RHPH2 by EcoRI and XbaI, and ligating them together at the EcoRl and Xbal sites to form the plasmid pBIG4;
(c) PCR amplifying the up- and down-stream arms of ura5 gene and ligating them together by using fusion PCR to form knockout DNA sequence;
(d) digesting the KOura5 knockout DNA sequence and pBIG4 by EcoRI and KpnI, and ligating them together to form plasmid pBIG4KOura5.

### Claim 7 (depends on 6)

The method according to claim 6, characterized in that the knockout DNA sequence in step (c) is constructed as the following steps:
designing the primers according to the sequence data of NCBI:
P1:
GACCGGAATTCCGACGCTGACATTACACATTTATCC
P2:
TGACGGTGGTGCAGGCCAGAGGGCCAAAGATGATGTCGTGCTCAATG
P3:
TTGAGCACGACATCATCTTTGGCCCTCTGGCCTGCACCACCGTCATT
P4:
TGCGGGGTACCCATGCGAATCACAGATATGG
subsequently, PCR amplifying up- and down-stream DNA fragments by using P1/P2 and P3/P4 with M. alpina ATCC 32222 genome DNA as template, then performing fusion PCR by using P1/P4 with up- and down-stream DNA fragments as templates to amplify the KOura5 knockout DNA sequence.

### Claim 8 (depends on 7)

The method according to claim 7, characterized in that the following primers are designed according to the sequence of pBluescript II SK+:
MCSF:
TTTCGCTAGCACGACGTTGTAAAACGACGGCCAGT
MCSR:
AACAACAATTGGGGCTCCACCGCGGTGGCGGCCG
Then the MCS DNA fragment in step (a) is amplified by PCR using primer pair MCSF/MCSR with pBluescript II SK+ as template.

### Claim 9 (depends on 8)

The method according to claim 8, characterized in that the A. tumefaciens mediated gene knockout method consists in using the ATMT method to transform M. alpina, specified as follows: mixing equal volume of 100 μL of A. tumefaciens and M. alpina spores, then spreading on the cellophane membrane placed on the IM solid medium, after co-cultivation, screening and obtaining the uracil auxotrophic strains of M. alpina.

### Claim 10 (depends on 9)

The method according to claim 9, characterized in that the steps of ATMT comprise:
(i) separating the A. tumefaciens harboring pBIG4KOura5 (preserved at the temperature of −80° C.) by stripping on the TEP solid plate (containing 100 μg/mL rifampicin and 100 μg/mL kanamycin) to obtain single clone by culturing at the temperature of 30° C. for 48 h;
(ii) transferring a single clone to 20 mL YEP medium (containing 100 μg/mL rifampicin and 100 μg/mL kanamycin) and culturing at the temperature of 30° C. for 48 h with shaking at 200 rpm in the dark;
(iii) collecting A. tumefaciens by centrifuging at 4000×g for 5 min, after removing the suspension, suspending the pellet by 5 mL of IM medium, followed by a centrifugation at 4000×g for 5 min, removing the suspension, then adding 2 mL of IM medium to suspend the bacterium;
(iv) adjusting the concentration of the bacterium suspension to OD600=0.9, followed by a dark cultivation at the temperature of 30° C. to OD600=1.5;
(v) collecting the M. alpina spores and counting the number, then adjusting the spore concentration to 106/100 μL;
(vi) mixing equal volume of 100 μL of A. tumefaciens and spores and spreading on the cellophane membrane placed on the IM solid medium, then incubating at the temperature of 23° C. for 48 to 96 h in the dark;
(vii) transferring the cellophane membrane onto GY plate containing 100 μg/mL cefotaxime, 100 μg/mL spectinomycin and 0.05 g/L uracil, then incubating at the temperature of 25° C. to 30° C. until spores appears.
